Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from camellia
Reexamination Certificate
2006-05-02
2006-05-02
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from camellia
C424S725000, C424S736000, C424S752000, C424S774000, C424S776000, C424S777000
Reexamination Certificate
active
07037533
ABSTRACT:
The present invention related to a functional agent for decomposing nicotine and a method of preparing the same. The agent includes natural plant extracts such as green tea leaves, mulberry leaves, ginkgo nuts, celery, lemon, apple, dried orange peel, and licorice root. The functional agent of the present invention facilitates the decomposition of nicotine and inhibits the generation of carcinogen. In addition, the functional agent shows an anti-oxidant effect, inhibits mutation and remarkably reduces the generation rate of lung cancer.
REFERENCES:
patent: 5087671 (1992-02-01), Loeppky et al.
patent: 1161857 (1997-10-01), None
patent: 2255081 (1975-08-01), None
patent: 010014750 (2001-02-01), None
Damaj, M.I., Welch, s.P. and Martin, B.R. (1996) J. Pharmacol. Exp. Thr., 277 454-461.
Magee, P.N., and Barnes, J.M. (1956) Br. J. Cancer, 10. 114-122.
Druckrey, H., Preussmann, R., Ivankovic, S., and Schmahl, D. (1967) Z. Krebsforsch, 69, 103-201.
Preussmann, R., and Stewart, B.W. (1984) N-nitroso carcinogens. In Chemical Carcinogensis, (Searle, C.E., Ed.) pp. 643-828, American Chemical Society, Washington, D.C.
Bogovski, P., and Bogovski, S. (1981) Int. J. Cancer, 27, 471-474.
Duckrey, H., and Preussmann, R. (1962) Die Naturwissenschaften, 49, 498-499.
Boyland, E., Roe, F.J.C., and Gorrod, J.W. (1964) Nature, 202, 1126.
Boyland, E., Roe, F.J.C., and Gorrod, J.W., and Mitchley, B.C.V. (1964) Br. J. Cancer, 18, 265-270.
Smith, P.A. S., and Loeppky, R.N. (1967) J. Am. Chem. Soc., 89, 1147-1152.
Klus, H., and Khuh, H. (1975) Fachliche Mitteiulungen der Austria Tabakwerke A.G., 16, 307-317.
Hecht, S.S., chen, C.B., Dong, M. , Omaf R.M., Hoffmann, D., and Tso, T.C. (1977) Beitr. Tabakforsch., 9, 1-6.
Hecht, S.S., Chen, C.B., and Hoffmann, D. (1976) Tetrahedron Let., 8, 503-506.
Hecht, S.S., Chen, C.B., Omaf, R.M., Jacobs, E., Adams, J.D., and Hoffmann, D. (1978) J. Org. Chem., 43, 72-76.
Hecht, S. S., Chen, C. B., Dong, M., Omaf, R. M., Hoffmann, D., and Tso, T. C. (1977).
Cashman, J. R., Park, S. B., Yang, Z. C., Wrighton, S. A., Jacob. P. III., and Benowitz, N. L. (1992)Chem. Res. Toxicol., 5,639-646.
Benowitz, N. L., Jacob. P. III., and Fong, I. (1994)J. Pharmacol. Exp. Ther., 268,296 303.
Kyerematen, G. A., Morgan, M. L., Chattopadhyay, B., deBethizy, J. D., and Vesell, E. S. (1990)Clin. Pharmacol. Ther., 48,641-651.
Caldwell, W. S., Greene, J. M., Byrd, G. D., Chang, K. M, Uhrig, M. S., deBethizy, J. D., Crooks, P. A., Bhatti, B. S., and Riggs, R. M. (1992)Chem. Res. Toxicol., 5,280-285.
Byrd, G. D., Chang, K-M., Greene, J. M., deBethizy, J. D. (1992)Drug, Metab. Dispos., 20, 192-197.
Jacob. P. III., Benowitz, N. L., and Shulgin, A. T. (1998)Pharmacol. Biochem. Behav., 30, 249-253.
Brown, B. G., Ching-jey, G. C, Paul, H. A., Chin, K. L., and David, J. D. (1999)Toxicol Scien., 47, 33-39.
Brunnemann, K. D., et al. (1991)Crit Rev Toxicol., 21(4),235-40.
Barlow, R. D., Stone, R. B., Wald, N. J., and Puhakainen, E. V. J. (1987)Clin. Chim. Acta., 165,45-52.
Lee DH. (1998)J. Biochem. Molecular Biology, 31 (2), 196-200.
Joseph, D., Lajos H., Nigel, H., Stanley, I. R., and Timothy, T. (1992)J. Chromatogr., 579, 93-98.
Yamazaki, H., Inui, Y., Yun, C. H., Guengerich, F. P., and Shimada, T. (1992)Carcinogenesis, 13, 1789-1794.
Code, E., Crespi, C., Penman, B., Gonzalez, F., Chang, T., and Waxman, D. (1997)Drug Metab. Dispos., 25,985-993.
Maron, D., Ames, B. N. (1983) Revised methods for the Salmonella mutagenicity test.Mutation Research, 113, 173-215.
Palinski, W., Rosenfeld, M. E., Yla, H. S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy S, Carew, T. E., Steinberg, D., and Witztum, J. L. (1989)Proc. Natl. Acad. Sci., 86, 1372-1376.
Hammond, B., Kontos, H. A., and Hess, M. L. (1985)Can J. Physiol. Pharmacol., 63, 173-187.
Cheeseman, K. H., and Forni, L. G. (1988)Biochem. Pharmacol., 37,4225-4233 Weitzman, S. A., Weitberg, A. B., Clark, E. P., and Stossel, T. P. (1985)Science, 227, 1231-1233.
Weitzman, S. A., Weitberg, A. B., Clark, E. P., and Stossel, T. P. (1985)Science, 227, 1231-1233.
Fantone, J. C., and Ward, P. A. (1985)Human Pathol., 16,973-978.
Yoshida, M., Sakai, T., Hosokawa, N., Marui, N., Matsumoto, K., Fujioka, A., Nishino, H., Aoike, A. (1990)FEBS Lett.15;260(1):10-3.
Agullo, G., Gamet, L., Besson, C., Demigne, C., Remesy, C. (1994)Cancer Lett.25;87(1 ):55-63.
Hoffmann, D., Rivenson, A., Chung, F-L., and Hecht, S. S. (1991)Crit. Rev. Toxicol., 21, 305-311.
Wang, Z. Y., Hong, J. Y., Huang, M. T., Reuhl, K. R., Conney, A. H., and Yang, C. S. (1992)Cancer Res.52, 1943-1947.
Xu, Y., Ho, C-T., Amin, S. G., Han, C., and Chung, F-L. (1992)Cancer Res.52, 3875-3879.
Chung, F-L., Wang, M., Rivenson, A., Iatropoulos, M. J., Reinhardt, J. C., Pittman, B., Ho, C. T., and Amin, S. G. (1998)CancerRes.58,4096-4101.
CN 1176749 A (Liu S) Mar. 25, 1998 (ABSTRACT).
CN 1100322 A (Song X) Mar. 22, 1995 (ABSTRACT).
CN 1116053 A (Tan R) Feb. 7, 1996 (ABSTRACT).
CN 1084018 A (Dong Fang Medical Treatment & Health Care) Mar. 23, 1994 (ABSTRACT).
CN 1242210 A (Chenggong Patent Tech Res Inst Wuhao Cit) Jan. 26, 2000 (ABSTRACT).
Ferry, D. R., Smith, A., Malkhandi, J., Fyfe, D. W., deTakats, P. G., Anderson, D., Baker, J., Kerr, D. J. (1996)Cancer Res, 2(4):659-68.
Scambia, G., Ranelletti, F. 0., Benedetti, Panici, P., Piantelli, M., Bonanno, G., De Vincenzo, R., Ferrandina, G., Pierelli, L., Capelli, A., Mancuso, S. (1991)Cancer Chemother Pharmacol.28(4): 255-8.
Larocca, L. M., Piantelli, M., Leone, G., Sica, S., Teofili, L., Panici, P. B., Scambia, G., Mancuso, S., Capelli, A., Ranelletti, F. 0. (1990) Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids.Br J Haematol.75(4):489-95.
Scambia, G., Ranelletti, F. 0., Benedetti, Panici, P., Bonanno, G., De Vincenzo, R., Piantelli, M., Mancuso, S. (1990) Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth.Anticancer Drugs.1 (1 ):45-8.
Altern. Med Rev. 1999 “Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer”, Brown MD; NCBI.
J. Korean Soc Food Sci. Nutr., “Effects of Water-Soluble Extract from Leaves ofMorus albaandCudrania tricuspidataon the Lipid Peroxidation in Tissus of Rats”, 6 pages.
Free Radical Res. 1999, “The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute”, NCBI, Paganga et al.
Yao Xue Xue Bao. 1989:24 “Effects of glycyrrhiza flavonoid on lipid peroxidationand active oxygen radicals”, Ju et al.,m NCBI.
Phytother Res. 1999; “Additional information to the in vitro antixoidant activity of Ginkgo biloba L.”, Lugas et al, NCBI.
Chem Pharm Bull Jul. 1992; Studies on natural antixodants in citrus species 1. Determination of antioxidative activities of citrus fruits' Tanizawa, et al., NCBI.
Jung Jong-Moon
Kim Eun-Ju
Kim Ji-Hoon
Park Myoung-Gyu
Blakely & Sokoloff, Taylor & Zafman
Jung Jong-Moon
Regen Biotech, Inc.
Tate Christopher R.
LandOfFree
Functional agent for decomposing nicotine and method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functional agent for decomposing nicotine and method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functional agent for decomposing nicotine and method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3550596